Raynews

Rayner’s Galaxy spiral IOL achieves nationwide reimbursement in Australia

Posted on 1/03/2026

Australian cataract patients can now gain broader access to next-generation lens technology, after Rayner secured Medical Device and Human Tissue Advisory Committee (MDHTAC) acceptance and Prostheses List (PL) reimbursement for RayOne Galaxy, effective 1 March 2026. RayOne Galaxy is the world’s first spiral IOL, representing a significant advancement in premium lens replacement technology. Developed with

Read more

Uncategorised

Designed for patient education, built to reduce clinic workload: New AI-powered patient platform eyejourney from Innoptix

Posted on 2/02/2026

When patients leave a consultation, they forget 80% of what they were told within 24 hours1 – and when critical information doesn’t stick, ophthalmology clinics are left managing anxious patients and a high administrative burden. eyejourney is the solution. Launching today, eyejourney is a personalised, AI-powered patient education platform designed to bring clarity, consistency and

Read more

Company

Rayner unveils revolutionary Sophi Phaco system in the US

Posted on 14/01/2026

Rayner has secured US Food and Drug Administration (FDA) 510(k) clearance for Sophi, the Swiss-engineered phacoemulsification system set to redefine efficiency for US cataract surgeons. Sophi (Swiss Ophthalmology Innovation) brings a bold new philosophy to the operating room: maximum productivity, without compromise. Packed with features tailored to meet the demands of ASCs, office-based surgery and

Read more

Company

Rayner Secures FDA Approval for RayOne EMV Toric IOL

Posted on 13/10/2025

FDA approval expands US access to award-winning lens technology Rayner today announced that the US Food and Drug Administration (FDA) has approved its RayOne EMV Toric intraocular lens (IOL) following the successful completion of a pivotal Investigational Device Exemption (IDE) study. The lens is now available to US surgeons seeking to deliver high quality visual

Read more

Company

St. Thomas’ PCO Study Clarifies Debate on IOL Materials: No Difference Between Hydrophilic and Hydrophobic Lenses

Posted on 15/09/2025

15 September 2025 | Worthing, UK  The results of a landmark study comparing hydrophilic and hydrophobic intraocular lenses (IOLs), presented at the 2025 ESCRS Congress, has confirmed both IOL materials can be clinically and statistically equivalent in preventing posterior capsular opacification (PCO). The safety of hydrophilic IOLs compared to hydrophobic IOLs has been a subject

Read more

Company

Rayner’s EMV lens wins prestigious King’s Award for Enterprise 2025

Posted on 6/05/2025

6 May 2025 Rayner, a global provider of solutions for cataract surgery and the only manufacturer of intraocular lenses (IOLs) in the UK, proudly announces today that it has been honoured with the prestigious King’s Award for Enterprise 2025 for its innovative RayOne EMV increased range of focus IOL. RayOne EMV, which launched in 2020,

Read more

Company

Rayner doubles IOL manufacturing capacity to meet growing demand

Posted on 2/04/2025

02 April 2025 | In response to demand growth, Rayner – a global leader in solutions for cataract surgery – has completed an extensive expansion of its Worthing (UK) production facility, doubling the number of intraocular lenses (IOLs) it can manufacture annually to 4 million. Since opening its purpose-built manufacturing facility in 2017, every Rayner

Read more

Company

Rayner completes pivotal dropless cataract surgery study with OMIDRIA®

Posted on 25/03/2025

In a major step toward redefining postoperative care and elevating patient experience, Rayner – a global leader in cataract surgery products – proudly announces the successful completion of its pivotal U.S. dropless cataract surgery study. OMIDRIA (phenylephrine and ketorolac intraocular solution 1% / 0.3%) is the only FDA-approved NSAID for use during cataract surgery, indicated

Read more

Company

Rayner completes recruitment for RayOne Galaxy IOL IDE

Posted on 3/02/2025

03.02.25 | Just 18 weeks on from the first implantation, Rayner is delighted to announce that it has now closed recruitment in the Investigational Device Exemption (IDE) study for the RayOne Galaxy intraocular lens in the USA. Developed in collaboration between Rayner, a global manufacturer of cataract surgery solutions, and ophthalmologist Dr João Lyra from

Read more

Company

RayOne EMV Toric receives Health Canada approval

Posted on 23/01/2025

Mississauga, ON | 21 January 2025 Rayner, a global manufacturer of products for cataract surgery based in Worthing, UK, is pleased to announce the approval of RayOne EMV Toric (RAO210T) by Health Canada. Developed in collaboration with Professor Graham Barrett, RayOne EMV and RayOne EMV Toric are the only patented aspheric IOLs that induce controlled

Read more

Company